spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online June 29, 2006
Journal of Experimental Biology 209, 2794-2803 (2006)
Published by The Company of Biologists 2006
doi: 10.1242/jeb.02307
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofer, S.
Right arrow Articles by Homberg, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofer, S.
Right arrow Articles by Homberg, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evidence for a role of orcokinin-related peptides in the circadian clock controlling locomotor activity of the cockroach Leucophaea maderae

Sabine Hofer and Uwe Homberg*

Fachbereich Biologie, Tierphysiologie, Philipps Universität Marburg, D-35032 Marburg, Germany


Figure 1
View larger version (145K):

[in a new window]
 
Fig. 1. Confocal laser images obtained from vibratome sections of the accessory medulla. Orcokinin immunoreactivity is shown in green (Ai,Bi,Ci,Di) and Texas Red dextran (TRed-D) fluorescence in red (Aii,Bii,Cii,Dii). (Aiii,Biii,Ciii,Diii) Colocalization of orcokinin immunoreactivity and TRed-D fluorescence in yellow. Stacks of 7-11 optical sections (z-distance between single sections=2 µm). (Ai-iii) The TRed-D-injected accessory medulla (outlined by the dotted line). Arrowheads point to the injection site. (Bi-iii) The contralateral accessory medulla (AMe) after injection of TRed-D into the opposite AMe revealed one colabeled orcokinin/TRed-D fluorescent ventral neuron (VNe; arrowheads). (Ci-iii) Section posterior to B. Near the AMe, one ventromedian neuron (VMNe, arrowheads) shows anti-orcokinin/TRed-D colabeling. Colabeled fibers from the injected AMe project via the lobula valley tract (arrows) into the anterior and internodular neuropil of the contralateral AMe. (Di-iii) Section posterior to C. Two additional VMNe (arrowheads) and fibers in the lobula valley tract (arrows) show colabeled anti-orcokinin/TRed-D fluorescence. Scale bars, 50 µm.

 

Figure 2
View larger version (62K):

[in a new window]
 
Fig. 2. Confocal laser images obtained from vibratome sections of (A) the anterior- and (B) posterior optic commissure. Green shows orcokinin immunoreactivity (Ai,Bi), red shows Texas Red dextran (TRed-D) fluorescence (Aii,Bii), after injection of TRed-D into one AMe (see Fig. 1A). The right column (Aiii,Biii) shows colocalization of orcokinin immunoreactivity and TRed-D fluorescence in yellow. Stacks of 10 optical sections (z-distance between single sections=1 µm). (Ai-iii) Orcokinin-ir and TRed-D fluorescent fibers project in parallel via the anterior optic commissure (arrowheads), but do not show colabeling. (Bi-iii) Colabeled orcokinin/TRed-D fluorescent fibers in the posterior optic commissure (arrowheads). Scale bars, 50 µm.

 

Figure 3
View larger version (52K):

[in a new window]
 
Fig. 3. Three-dimensional model of the cockroach brain showing orcokinin-ir (blue, green) and PDF-ir (red) connections between both AMae. Three ventromedian neurons (VMNe, blue, p) project via the posterior optic commissure (POC) into the contralateral AMe and arborize in several median layers of the medulla. One ventral neuron (VNe, green) projects via an unidentified commissure. One PDF-ir VNe (red, p) projects via the POC and two PDF-ir VNe (a) via the anterior optic commissure (AOC) to the contralateral AMe and into the distalmost layer of the medulla (Reischig et al., 2004Go). The 3D model was provided by T. Reischig and modified. Scale bar, 200 µm.

 

Figure 4
View larger version (36K):

[in a new window]
 
Fig. 4. Records of circadian wheel-running activity (A,C) and plots of activity onsets of cockroaches kept in constant darkness (B,D). (A,B) After injection of 150 fmol of Asn13-orcokinin in 2 nl saline at CT14 of day 10 (arrow in A), regression analysis through consecutive activity onsets (B) revealed a phase delay {Delta}{varphi} of 3.7 circadian hours (hct). (C,D) After injection at CT18 of day 10 (arrow in C), the regression analysis through consecutive activity onsets (D) revealed a phase advance {Delta}{varphi} of 2.2 hct.

 

Figure 5
View larger version (16K):

[in a new window]
 
Fig. 5. Orcokinin- and saline-dependent phase shifts at different circadian times (CT; hct). (A) Orcokinin injections (150 fmol in 2 nl saline with blue food dye, N=50) caused maximal phase delays during the early subjective night (up to -3.8 hct at CT13) and maximal phase advances during the middle of the subjective night (up to 2.2 hct at CT18). (B) Control injections (2 nl saline with blue food dye, N=46) caused small and non-significant phase shifts in both directions except for a significant phase delay at CT22. (C) Phase-response curves obtained in response to 150 fmol Asn13-orcokinin and control injections. Data were merged into 2 h bins. Orcokinin-dependent phase shifts (black) and phase shifts following control injections (gray) are plotted. Black asterisks indicate orcokinin-dependent phase shifts that were significantly different (P<0.05) from control injections at the same CT. The grey asterisk indicates control injections that produced phase shifts that were significantly different from zero.

 

Figure 6
View larger version (11K):

[in a new window]
 
Fig. 6. Dose dependency of Asn13-orcokinin-induced phase shifts between CT13 and CT15. Bars show phase shifts resulting from injections of saline (N=6), 1.5x10-6 fmol orcokinin (N=6), 1.5x10-2 fmol orcokinin (N=8), and 150 fmol of orcokinin (N=5) in 2 nl saline. Asterisks indicate orcokinin doses that induced phase shifts significantly different from control injections (P<0.05).

 

Figure 7
View larger version (22K):

[in a new window]
 
Fig. 7. Smoothed phase-response curves for injections of 150 fmol orcokinin (black) compared with the phase-response curve for 6 h light-pulses [blue (Page and Barrett, 1989Go)], GABA (red) and allatotropin (dotted line) injections (Petri et al., 2002Go).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2006